Observational studies show that people with diabetes using GLP1 therapies tend to have lower rates of dementia compared to those on other treatments
recently employed complementary in vitro and in vivo methods to examine how altered MET signaling impacts synaptic development, observing an opposite effect on neuronal morphology in a stage-dependent way
Maybe this is a question thats been answered by the sell side
Setting Realistic Expectations for Results PT-141, also known as bremelanotide, is designed to work with your brain to enhance sexual desire
Thats because the bodys response to GLP-1 is complex
Svetlana Mojsov, a researcher at Rockefeller University whose work has been important in the characterization of GLP-1 and clarification of its role in glucose metabolism, explained in an interview with PNAS this September, Once we solve obesity, I think a lot of other disorders will be taken care of As for all the other pathophysiological states in which GLP-1-based drugs appear to be beneficial, I think it may have something to do with the drugs central role in regulating glucose metabolism. But lowering glucose isnt GLP-1s only job, though as Mojsov said, the relationship with glucose metabolism may be a crucial central part in the many related conditions it seems to treat
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
